Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.7400
+0.0140 (1.93%)
Jun 24, 2026, 12:30 PM EDT - Market open
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $160.58 million as of June 24, 2026. Its market cap has increased by 82.81% in one year.
Market Cap
160.58M
Enterprise Value
86.77M
1-Year Change
82.81%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $160.58M, a decrease of -73.40%. That is a compound annual growth rate of -23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 151.90M | -1.39% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 170.66M |
| OnKure Therapeutics | 169.66M |
| TuHURA Biosciences | 168.12M |
| Kazia Therapeutics | 167.86M |
| Caribou Biosciences | 164.64M |
| Corbus Pharmaceuticals Holdings | 156.75M |
| Humacyte | 155.50M |
| Tiziana Life Sciences | 150.00M |